Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by dudzik on Saturday June 12, 2021 @01:15AM (#27481740)

Agreed, it is not to be expected that a doctor is able to follow the scientific literature for hundreds of different topics. However, I would expect a specialist to know their field well enough to assist a patient/guardian in making a somewhat informed decision.

I take your point that companies can falsely advertise their products. I think there is a place for a government body to make sure claims about healthcare products are factual. In this particular case we are talking about a drug that appears to not cause any harm. So I don’t see any reason to prevent an adult to make a decision with the help of a physician to administer said drug.

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by acdha on Sunday June 13, 2021 @02:57PM (#27495238)

> I take your point that companies can falsely advertise their products. I think there is a place for a government body to make sure claims about healthcare products are factual.

The problem is that deciding whether something is factual is a lot easier for simple things. For something like this, there are vaguer connections between facts like plaque removal and more nebulous things like meaningful outcomes for patients.

> In this particular case we are talking about a drug that appears to not cause any harm.

Other than brain swelling or bleeding, headache, falling, diarrhea, and confusion, delirium or disorientation, you mean?

[ Parent | on HN ]